US 8226980
Orally disintegrating solid dosage forms comprising progestin and methods of making and using thereof
granted A61KA61K31/56A61K9/0056
Quick answer
US patent 8226980 (Orally disintegrating solid dosage forms comprising progestin and methods of making and using thereof) held by TEVA WOMEN'S HEALTH, INC. expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA WOMEN'S HEALTH, INC.
- Grant date
- Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/56, A61K9/0056, A61K9/2018, A61K9/2054